Pharmaceutical IP and competition law in France: overview | Practical Law
A Q&A guide to pharmaceutical IP and competition law in France.
Enter to open, tab to navigate, enter to select
US Home
Global Home
NEW
Sign in
Sign in
All content
Search:
Search Westlaw
Search Tips
Advanced
Pharmaceutical IP and competition law in France: overview
Practical Law Country Q&A 4-615-9355
(Approx. 17 pages)
Pharmaceutical IP and competition law in France: overview
by
Marie Fillon, Mélanie Thill-Tayara
and
Marion Provost
, Dechert LLP
Related Content
Law stated as at 01 May 2018
•
France
A Q&A guide to pharmaceutical IP and competition law in France.
The Q&A gives a high level overview of key issues including patents, trade marks, competition law, patent licensing, generic entry, abuse of dominance and parallel imports.
For information on pharmaceutical pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, and product recall and liability, visit
Medicinal product regulation and product liability in France: overview
.
To compare answers across multiple jurisdictions, visit the Pharmaceutical IP and competition law
Country Q&A tool
.
The Q&A is part of the global guide to life sciences law. For a full list of jurisdictional Q&As visit
www.practicallaw.com/lifesciences-guide
.